Status:
COMPLETED
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Dey
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to determine the appropriate dose of fluticasone propionate/formoterol fumarate that is closest to Advair Diskus (fluticasone propionate/salmeterol xinafoate using pulmonar...
Eligibility Criteria
Inclusion
- Diagnosis of COPD
- Female of child-bearing potential to use adequate birth control
- Smoker or ex-smoker with history of at least 10 years of smoking at least one pack of cigarettes per day
- Meet lung function requirements
Exclusion
- Diagnosis of asthma
- Other significant disease than COPD
- Pregnant or lactating female
- Female planning to become pregnant
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
457 Patients enrolled
Trial Details
Trial ID
NCT00403286
Start Date
November 1 2006
End Date
May 1 2007
Last Update
June 30 2009
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Birmingham, Alabama, United States, 35209
2
Research Site
Jasper, Alabama, United States, 35501
3
Research Site
Phoenix, Arizona, United States, 85006
4
Research Site
Buena Park, California, United States, 90620